HBVAXPRO sol inj 10 mcg ser pré 1 ml
7680006630017
CH-663
J07BC01
08.08.
1 / 3
google
Details
- Product number
- 0066301
- CPT
- -
- Packaging group
- 1 x 1 ml
- Unit
- Fertigspritze(n)
- Composition
- hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxyphosphas sulfas amorphus, borax, natrii chloridum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 3.5 mg.
Articles (1)
HBVAXPRO 10, Injektionssuspension
Injektionssuspension
1 x 1 ml
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.5 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 43.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2007
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 663
- Drug name
- HBVAXPRO 10, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07BC01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/08/2002
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HBVAXPRO susp inj 10 µg 1x1ml pce
- Description (DE)
- HBVAXPRO Inj Susp 10 µg 1x1ml Stk
- Market launch
- 20/08/2002
- Narcotic (BTM)
- No
Application methods
IMU